Insider trades

Scott N. Boyle, Chief Officer of C4 Therapeutics CCCC, has filed 0 purchases and 2 sales on the open market. The latest trade was on 02/14.

Scott N. Boyle

Chief Business Officer
First filing
23/02/15
Trades
31 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
02/14

Trading activity

Transactions

Trade type
CCCC
Open-market sale10b5-1 plan25/02/14–25/02/1825/02/181,159 sh2 trades$3.15avg.$3,650.85−1.1%